1. Home
  2. Browse
  3. National Institutes of Health
  4. RFA-NS-28-012

RFA-NS-28-012National Institutes of Health

Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional)

Deadline
Award ceiling
$2,500,000
Awards
3
Posted
Nov 3, 2026

Official announcement on Grants.gov · opens the funder's page. Always confirm dates there.

Summary

This Notice of Funding Opportunity (NOFO) supports the translation of genome editing and other biologic therapies for Alzheimer's Disease-Related Dementias (ADRD). The program spans the full translational pipeline, from therapeutic lead optimization and drug product development through IND-enabling studies and early clinical evaluation…

Preparing an application?

On Plus, $39 a month

  • The eligibility check against your profile: career stage, institution type, and the windows that close before the deadline does
Start with PlusSign in

Cancel any time. Browsing stays free.

Subjects

More from National Institutes of Health

Open now with at least two weeks to apply, soonest deadline first.

Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)

PAR-25-446National Institutes of Health3 review criteria on fileagency framework

$3M

Cellular Senescence Network (SenNet): SenNet Technology Projects (SenTecs) (UG3/UH3 Clinical Trial Not Allowed)

RFA-RM-27-007National Institutes of Health

—

Cellular Senescence Network (SenNet): SenNet Data Coordination and Integration Center (SenNet DCIC) (UM1 Clinical Trials Not Allowed)

RFA-RM-27-025National Institutes of Health

—

HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional)

RFA-AT-25-003National Institutes of Health3 review criteria on file

$375k

Everything open from National Institutes of Health

Related by subject

Open opportunities sharing the most subjects with this one (Alzheimer's, Neurodegeneration), with at least two weeks to apply.

Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)

PAR-25-248National Institutes of Health3 review criteria on file

—

NIA Expanding Research in AD/ADRD (ERA) Summer Research Education Program (R25 Independent Clinical Trial Not Allowed)

RFA-AG-26-011National Institutes of Health8 review criteria on file

$200k

NIA Expanding Research in AD/ADRD (ERA) Postbaccalaureate Research Education Program (R25 Independent Clinical Trial Not Allowed)

RFA-AG-26-010National Institutes of Health9 review criteria on file

$400k

Everything open tagged Alzheimer's

Hiring in this research area now

All neuroscience jobs

Source record: https://www.grants.gov/search-results-detail/361287Via Grants.gov. Last checked against the source . Always confirm dates with the funder.